Por: The Boston Globe Business September 27, 2022
LIFE SCIENCESBiogen to pay $900m to settle whistle-blower suit over kickbacksAfter a decade of litigation, Biogen has agreed to pay $900 million to settle a federal whistle-blower lawsuit by a former employee who accused the Cambridge-based drug firm of paying kickbacks to hundreds of doctors to get them to prescribe its multiple sclerosis drugs. Under the terms of the settlement, Biogen will pay more than $843 million to the US government and... + full article
Associated Press USA Health September 28, 2022
BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said.The agreement announced Monday settles a whistleblower... + más
Biogen to pay $900M to settle allegations of improper physician kickbacks | Fox Business
Biogen pays $900M to settle doctor kickback allegations | Orlando Sentinel
The Boston Globe USA Business September 27, 2022
After a decade of litigation, Biogen has agreed to pay $900 million to settle a federal whistle-blower lawsuit by a former employee who accused the Cambridge-based drug firm of paying kickbacks to hundreds of doctors to get them to prescribe its multiple sclerosis drugs. Under... + más
Biogen to pay $900m to settle whistle-blower suit over kickbacks | The Boston Globe
Orlando Sentinel USA Business September 27, 2022
BOSTON — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. The agreement announced Monday settles a whistleblower... + más
Biogen pays $900M to settle doctor kickback allegations | ABC News
ABC News USA Business September 27, 2022
BOSTON -- Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said.The agreement announced Monday settles a whistleblower lawsuit... + más
Chicago Tribune USA Business September 27, 2022
Fox Business USA Business September 27, 2022
Aflac Chairman and CEO Dan Amos says record-high inflation poses a ‘challenging environment’ for consumers. Biogen has to settle allegations that it paid kickbacks to persuade doctors to prescribe its multiple sclerosis drugs. The settlement comes after former Biogen... + más
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs | CNBC
CNBC USA Health September 27, 2022
In this articleA Biogen facility in Cambridge, Massachusetts.Brian Snyder Reuters will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs, the Justice Department announced on Monday.A former Biogen employee... + más
About iurex | Privacy Policy | Disclaimer |